Da
En
Fr
De
Sv
Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software & TMT
Research
Equity Research
Macro and markets
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
Da
En
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
28 feb 2024
Equity Research Mindark PE, Q4 2023: Adjusted accounting principles contribute to high net revenues
Equity Research
Mindark PE
07 dec 2023
Equity Research Mindark PE, Q3 2023: Growth as expected
Equity Research
Mindark PE
28 nov 2023
Equity Research Mindark PE, First impression Q3 2023: Revenues as expected, but still high capitalized development costs
Equity Research
Mindark PE
04 okt 2023
Initiation of coverage Mindark PE: Renewal and improvements followed by growth
Equity Research
Mindark PE